Study design
This study will be a single (assessor) blind, three-arm parallel, multi-center RCT. The outline of the study protocol is shown in Fig. 1. The protocol for this study is reported in accordance with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Checklist (Additional file 1).
Study setting
The study will be conducted at four tertiary hospitals in Kano, Kano State, Northwestern Nigeria; Muhammad Abdullahi Wase Teaching Hospital (MAWTH), Murtala Muhammad Specialist Hospital (MMSH), Aminu Kano Teaching Hospital (AKTH), and National Orthopedic Hospital, Dala (NOHD). These centers were chosen to have the required number of participants.
Training of physiotherapists/research assistants
Prior to the commencement of the study, two licensed physiotherapists with at least two years of clinical experience will be recruited as research assistants in each of the four hospitals. One physiotherapist will be responsible for eligibility and outcome (baseline and follow-up) assessments. This physiotherapist will be blinded to group allocation. The other physiotherapist will be responsible for treatment. All the physiotherapists will receive a two-day training on the study procedures by the lead investigator (AIA).
Participants’ recruitment and eligibility
Participants for this study will be consecutive patients with knee OA referred to the physiotherapy department by the general practitioners in the four tertiary hospitals. Recruitment adverts using local posters with the contact of the primary investigator will be pasted at various notice boards in the selected hospitals. To be eligible for the study, participants must meet the clinical criteria for the diagnosis of knee OA according to the American College of Rheumatology (ACR) criteria for unilateral or bilateral symptomatic knee OA [48] in addition to being male or female of 30 to 65years old. They will be excluded if they have any history of knee, hip or ankle surgery prior to the study, peripheral vascular disease, local or systemic infection, deformity in lower limbs, rheumatic disease other than OA, high-risk health status for exercise, unresolved balance or neurological disorder and received intra-articular joint injection within 4 weeks of beginning the study or history of a lower extremity exercise program for a minimum of six weeks prior to enrolment.
Baseline assessment
Physiotherapists at each of the physiotherapy departments of the selected hospitals will assess potential participants for eligibility through clinical history, physical examination, and review of self-report questionnaires. After ensuring eligibility, participants will be given oral and written information regarding the procedures and potential risks of the study. Written informed consent will be then sought and obtained. Baseline socio-demographic and clinical variables such as age, gender, marital status, education level, occupational status, height, weight, body mass index, duration of knee pain, and side affected will be collected using a prepared proforma. Baseline self-report outcome assessments will include pain, physical function, quality of life, and knee stability. Baseline objective outcome assessment will be proprioception measurement. The flow of participants is depicted in Fig. 2.
Randomization and blinding
After completing the baseline assessment, the participants will be randomized into three intervention groups; twice-weekly KBA, thrice-weekly KBA, and conventional physiotherapy (control) in the ratio of 1:1:1. The randomization will be performed using an online randomization generator (http://www.randomization.com) by utilizing block randomization with a block size of 3 to 6. A third party who will be blinded to the study content will perform the randomization process. Allocation of participants will be concealed by using consecutive numbered, sealed, and opaque envelopes. The outcome assessors (physiotherapists) in this study will be blinded to the group allocation and will not be involved in administering the interventions. The participants will be told they are in a “twice weekly KBA” or “thrice-weekly KBA” or "conventional physiotherapy" but the type of intervention will not be specified. Conversely, due to the nature of the interventions, it will be difficult to blind the physiotherapists providing the treatments. Unbinding conditions will be only permissible when there is medical emergency.
Interventions
Participants in the conventional physiotherapy or control group will receive brief patient education, ultrasound therapy, stretching and strengthening exercises. The program will be delivered twice weekly for 8 weeks except for the education program which will be provided in two sessions. The stretching exercises will be performed as warm-up and cool-down. Participants in the twice-weekly KBA group will receive two sessions per week of KBA exercise program for 8 weeks whereas participants in the thrice-weekly KBA will receive three sessions per week of the same exercise program as for the twice-weekly KBA group. Both the two KBA groups will receive the same intervention program as described for the conventional group prior to receiving the KBA exercise program. All exercises will be delivered individually under the supervision of the treating physiotherapists. All lower-extremity exercises will be performed bilaterally. The participants will be instructed to perform exercises consistent with their group allocation two times per day at home. They will be encouraged also to perform a walking program of 30 minutes per day at least 3 to 4 days per week at home. To enhance compliance with the home program, a leaflet with descriptions and pictures of the exercises will be provided to the participants. However, exercises that are more challenging or those requiring the strict supervision of the therapist will be not advised for the home program.
Brief patient education
Prior to exercise interventions, the participants will receive a brief education lasting approximately 15 to 20 minutes. The program will be delivered by the therapist responsible for exercise intervention. It will be provided in a group of 3 to 5 or more participants to save effort. The key topics to be addressed include (1) understanding of knee OA, (2) lifestyle and physical activity/exercise, (3) diet and weight control, (4) self-management skills including active coping and pacing as well as correct use of medications (e.g. paracetamol), and (5) ergonomics and joint protection.
Ultrasound therapy (UST)
The affected knee of the participants will be treated with UST using the direct contact technique. A coupling medium (ultrasonic gel) will be used. The treatment parameters to be used include; frequency of 1MHZ, pulse duration of 2.0 W/cm2, pulse rest time of 1:1 (continuous mode), and 7-minute treatment time. The UST will precede the stretching and strengthening exercises.
Stretching and strengthening exercise
Participants will perform 3 lower-extremity stretching and strengthening exercises commonly prescribed for individuals with knee OA as described in previous studies [45,49]. The stretching includes; hamstring stretch, quadriceps stretch, and calf stretch for each limb. Each exercise will be held for 15 seconds and repeated 6 times, with 10 to 20 seconds rest between each exercise. The strengthening exercises include; static quadriceps isometrics, knee extension, and leg curl. Progression for the strengthening exercises will be made by increasing the number of sets from 15 seconds hold to 30 seconds hold when the 15 seconds hold is no longer challenging, and the patient is performing activity with ease and good form. However, the exercise will be discontinued if the patient reports an exacerbation of symptoms.
Kinesthesia, balance and agility exercise
The exercise regimen of KBA will be done by performing a series of walking-based agility and balance exercises. The exercise protocol was adapted from previous studies [42,44,45] but with slight modifications regarding the training intensity and addition of visual manipulation for some selected walking-based agility exercises. The participants will perform agility exercises before proceeding to static and dynamic balance exercises. For the agility exercises, participants will begin each exercise with a walking pace of approximately 15 steps and progress to a maximum of approximately 75 steps [44,45]. For the balance training, participants will start with exercises while standing on a hard surface or floor and then proceed to exercises while standing on a form surface (Balance Soft Mat, BigMall, Nigeria). The form provides a more difficult task compared to the hard floor. Static balance exercises will be performed before progressing to dynamic balance exercises. For example, static balance will begin with one-leg stand on a hard floor before progressing to one-leg stand on the trainer foam [45]. The dynamic balance exercises will be progressed in the same manner but will require perturbations in different directions to be provided by the therapists. Progression of each balance exercise to the next will be based on the participant’s ability by starting with the less stressful and challenging ones and increasing the number of repetitions. Participants will perform at least 3 sets of each exercise and there will be 10 to 20 seconds rest between each exercise. All exercises will be progressed according to the individual’s tolerance and abilities within the structure of the program. If an exercise proved very difficult, the duration of the exercise will be adjusted based on the patient’s ability but no activity will be eliminated. However, the exercise will be discontinued if the patient reports an exacerbation of symptoms. The details of the exercise program are presented in Table 1.
Outcome assessments and follow-ups
The primary outcomes will be physical function whereas the secondary outcomes will be pain, knee stability, proprioception, and quality of life. Similar to previous trials on knee OA, if only one knee of the patient is affected, the evaluation of the outcomes will be done for this knee. If the patient has bilateral affectation of which only one meets the ACR criterion [48], only this knee will be evaluated. However, if the patient is having bilateral affectation according to the ACR criterion, the more painful knee will be randomly selected for outcome evaluation.
All outcomes will be assessed pre-intervention, immediately post-intervention and at 3-month, 4-month, and 6-month post-randomization. Participants missing their regular appointments will be given makeup appointments until they reach the required sessions for each group. This will be done by contacting them through phone calls. All participants will be advised to refrain from other interventions during the trial except for those taking medications as prescribed by their physician and this information will be collected.
Physical function
The physical function of the participants will be assessed with the Hausa version of the Ibadan Knee and Hip Osteoarthritis Outcome Measure (IKHOAM) [50]. It is a 33-item instrument with 3 domains consisting of activity limitations, participation restrictions, and physical performance tests to assess physical function. Each item is rated on a Likert scale that ranges from 0 to 5. The measure is a Nigerian culture and environment-friendly clinical instrument developed for individuals with knee OA [51]. To obtain the patient’s percentage perceived level of physical function, the participant’s scores obtained are divided by the total possible score (232) and then multiplied by 100. Lower scores indicate a lower level of physical functioning [51]. The Hausa IKHOAM has been shown to be valid and reliable [50].
Pain intensity
The Visual Analogue Scale for pain (VAS-pain) will be used to assess participants’ pain severity. It represents the intensity dimension by a 100mm bidirectional plain line with anchor points of “no pain” (0mm) and “worst possible pain” (100mm) located at either end of the line [52]. Participants will be asked to rate their current level of pain. The VAS-pain has been shown to have adequate psychometric properties for measuring osteoarthritic knee pain [53]. The Hausa version of the VAS-pain has been shown to be reliable and valid [54] and will be used in this study.
Knee stability
Participants’ subjective reports of knee stability will be measured with the Knee Outcome Survey-Activities of Daily Living Scale (KOS-ADLS). It is a 14-item questionnaire that assesses symptom-related and specific functional limitations [55]. Six items assess knee symptoms (pain, stiffness, swelling, instability, weakness, and limping) and eight items assess functional limitations (walking, stairs ascent/descent, standing, kneeling, squatting, sitting, and rising from a sitting position) experienced in the last 1 to 2 days during the performance of daily activities. Each item is scored on a 6-point Likert scale (0–5 points) [56]. The score is transformed to a 0–100 point scale with the highest score indicating the absence of symptoms and functional limitations [55]. For the purpose of this study, only the item pertaining to knee instability symptoms will be evaluated.
Proprioception
The participants' knee proprioceptive range of motion will be measured using an electrogoniometer (Ergotest Technology, Norway; range: 15–320 degrees). The use of an electrogoniometer for measuring the relative position of the knee joint has ben has been shown to be a reliable method for assessing joint proprioception [57]. To measure the proprioceptive range of motion, the participants will be asked to wear shorts for ease of attachment of the electrogoniometer to the knee joint [58]. The participants’ eyes will be blinded to eliminate visual feedback. They will be asked to sit on a high plinth with the hip at an angle of 80 degrees flexion in such a way that the distal hamstrings and knee joint are hanging freely at a resting position of 85 degrees knee flexion. A thin foam will be wrapped around the tested knee to minimize cutaneous sensation feedback from the attachment of the electrogoniometer [59]. While keeping the knee in a neutral position, the electrogoniometer will be placed on the lateral side of the knee joint and its axis coinciding with the flexion/extension axis of the knee [60]. The goniometer will be kept in place using an elastic strap wrapped around the cushion padding. Participants will be instructed to bend the knee to a resting position of 85˚ of flexion and in this position, they will be instructed to bend from the resting position to the Target Angle (TA) of 70 degrees and hold there for 5 seconds, then return back to the resting position (85 degrees of flexion) [61,62]. The participants will be then asked to repeat the procedure of bending the knee from the resting position of 85 degrees and say ‘YES’ on perceiving they reached the target position of 70˚ and hold. This angle will be noted on the electrogoniometer and documented as the Perceived Angle (PA). The difference between TA and PA is the Absolute Angular Error (AAE), which will be documented [61]. This procedure will be repeated three times and the average of the three readings will be calculated and recorded as the error for each participant [57]. The inter-rater (between assessors) and intra-rater (within assessors) reliability of the electrogoniometer used in the present study will be evaluated.
Quality of life
The quality of life of the participants will be measure using the mini Osteoarthritis Knee and Hip Quality of Life Questionnaire (OAKHQOL) [63]. It is a 20-item questionnaire derived from the original 40-item questionnaire developed by Rat et al. [64]. The questionnaire consists of five dimensions subscales: physical activities, mental health, pain, social support, and social functioning; and three independent items addressing sexual life, professional life, and fear of being dependent. Each item is measured on a numerical rating scale from 0 to 10 and the mean item score becomes the corresponding dimension score [63]. The mini OAKHQOL has been shown to have good psychometric properties in terms of reliability, validity, and factorial structure in subjects with knee and hip OA [63,65].
As no Hausa version of the KOS-ADLS and OAKHQOL are available for use, these questionnaires will be translated from English into Hausa language using guidelines for the process of cross-cultural adaptation of self-report measures [66]. This is to ensure that reliable data is collected and participants who are unable to complete English measures are not excluded in the trial [67].
Adverse events
Based on the findings of our pilot study (unpublished data) no serious adverse events were reported with KBA exercise. However, all participants will be informed during recruitment of the possibility of experiencing common adverse events related to exercise interventions such as muscle pull, soreness, or cramp. They will be educated that these symptoms are temporary and self-limiting. Nonetheless, in case of any serious adverse events such as exacerbating joint pain, discernible joint swelling, and excessive fatigue they will be advised to report such events immediately to the primary investigator or treating therapists for assessment and prompt action. Any adverse events will be recorded and reported to the research ethics committee of the National Orthopaedic Hospital Dala, or Kano State Ministry of Health, Nigeria.
Sample size estimation
Based on the results of our pilot study (unpublished data), using the mean and SD of the primary outcome (physical function measures by IKHOAM), a priori sample size was calculated to detect a between-group difference of 6.5 points, assuming a standard deviation (SD) of 11.0 points, an effect size of 0.34, statistical power of 90%, and an alpha of 5% (two-tailed). The calculations suggested a sample size of 72 would be needed. However, while anticipating a 15% attrition rate (n = 12), a total sample size of 84 will be needed with 28 participants per group. The calculations were performed with the G-power 3.1.9.2 software (University of Dusseldorf, Dusseldorf, Germany) [68].
Statistical analysis
An independent statistician who will be blinded to the study procedures will conduct statistical analysis. The normality test of the data will be verified with the Shapiro–Wilk test and visual inspection of distribution plots. Intention to treat analysis will be considered with enrolled and randomized participants included in statistical analysis according to the group they were originally assigned, regardless of what treatment (if any) they received [69]. Descriptive statistics of mean and standard deviation will be used to summarize all continuous variables while frequency and percentages will be used to summarize all categorical variables. Mixed between-within subject ANOVA will be used to assess interaction effect (group x time), main effects for time, and between-subjects effect if the data is normally distributed. Friedman’s ANOVA and Kruskal–Wallis test will be used to analyze within-group changes and between-group differences, respectively if the data is not normally distributed. Post hoc analysis will be conducted for any significant between-group differences observed. Effects size will be also computed to determine the magnitude of change in outcomes. All data will be analyzed using SPSS version 23 (IBM Co., Armonk, NY, USA) at an alpha level of 0.05.
Data management
After baseline assessment, all participants will be recognized only by their initials and numbers. Data will be stored using paper files, computer hard drive, and electronically to have backup copy. All data values will be double-checked by assessors to check for errors and missing values before analysis.
Dissemination
The results of this study will be submitted for publication to an international peer-reviewed journal irrespective of whether the results are positive, negative, or inconclusive.